These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29052906

  • 1. Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.
    Lehner LJ, Reinke P, Hörstrup JH, Rath T, Suwelack B, Krämer BK, Budde K, Banas B.
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29052906
    [Abstract] [Full Text] [Related]

  • 2. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
    Fellström B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L.
    Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197
    [Abstract] [Full Text] [Related]

  • 3. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
    Bonani M, Balaphas A, Bedino G, Bühler L, Dutkowski P, Fausch K, Gluderer S, Graf N, Hirt-Minkowski P, Müllhaupt B, Schönholzer C, Schulz MM, Venzin R, Wüthrich RP.
    Swiss Med Wkly; 2021 Feb 15; 151():w20453. PubMed ID: 33638353
    [Abstract] [Full Text] [Related]

  • 4. Safety and Effectiveness of Once-Daily, Prolonged-Release Tacrolimus in De Novo Kidney Transplant Recipients: 5-year, Multicenter Postmarketing Surveillance in Japan.
    Wakasugi N, Uchida H, Uno S.
    Transplant Proc; 2018 Dec 15; 50(10):3296-3305. PubMed ID: 30577199
    [Abstract] [Full Text] [Related]

  • 5. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients.
    Bae EK, Chandran MM, Everitt MD, Benz E, Bock M.
    Clin Transplant; 2024 Aug 15; 38(8):e15417. PubMed ID: 39087462
    [Abstract] [Full Text] [Related]

  • 6. Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO).
    Hugo C, Weihprecht H, Banas B, Schröppel B, Jank S, Arns W, Schenker P, Rath T, Hergesell O, Feldkamp T, Hermann B, Schiffer M.
    Transplant Proc; 2021 Jun 15; 53(5):1484-1493. PubMed ID: 33610306
    [Abstract] [Full Text] [Related]

  • 7. Safety and Effectiveness of Conversion From Cyclosporine to Once-Daily Prolonged-Release Tacrolimus in Stable Kidney Transplant Patients: A Multicenter Observational Study in Japan.
    Usuki S, Uno S, Sugamori H, Tanaka H, Aikawa A.
    Transplant Proc; 2018 Dec 15; 50(10):3266-3274. PubMed ID: 30577196
    [Abstract] [Full Text] [Related]

  • 8. Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids.
    Baek CH, Kim CD, Lee DR, Kim YH, Yang J, Kim BS, Lee JS, Han SY, Kim SW, Lee S, Lee KW, Kong JM, Shin BC, Lee SH, Chae DW, Kwon YJ, Jiang H, Lee H, Park SK.
    Transplant Proc; 2019 Apr 15; 51(3):749-760. PubMed ID: 30979460
    [Abstract] [Full Text] [Related]

  • 9. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A, Min SI, Ahn S, Min SK, Hong HJ, Han N, Kim YS, Ahn C, Ha J.
    PLoS One; 2019 Apr 15; 14(11):e0224595. PubMed ID: 31689320
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial.
    Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A.
    Transpl Int; 2019 Jun 15; 32(6):614-625. PubMed ID: 30770608
    [Abstract] [Full Text] [Related]

  • 11. ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus.
    Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F, ADHERE study investigators.
    Transpl Int; 2017 Jan 15; 30(1):83-95. PubMed ID: 27754567
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.
    Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, Mourad M, Lõhmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ, Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients (ADVANCE) study investigators.
    Transplantation; 2017 Aug 15; 101(8):1924-1934. PubMed ID: 27547871
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.
    Transplant Proc; 2012 Jan 15; 44(1):124-7. PubMed ID: 22310595
    [Abstract] [Full Text] [Related]

  • 19. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
    Fellström B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L.
    Transplant Proc; 2020 Dec 15; 52(10):3238-3245. PubMed ID: 33218668
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.